High-dose therapy and stem cell transplantation in follicular lymphoma

Annals of Hematology

Volumn 78, Issue 5, 1999, Pages 203-211

  Friedberg, J W ^a   Freedman, A S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Allogeneic transplantation; Autologous transplantation; Follicular lymphoma

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; DRUG MEGADOSE; FOLLICULAR LYMPHOMA; HUMAN; MINIMAL RESIDUAL DISEASE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOMA, FOLLICULAR;

EID: 0033067142     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050503     Document Type: Review

References (62)

1. Horning SJ, Rosenberg SA (1984) The natural history of initially untreated low-grade non-Hodgkin's lymphoma. N Engl J Med 311:1471
2. Gallagher C, Gregory W, Jones A, Stansfeld A, Richards M, Dhaliwal H, Malpas J, Lister T (1986) Follicular lymphoma: prognostic factors for response and survival. J Clin Oncol 4:1470
3. Johnson P, Rohatiner A, Whelan J, Price C, Love S, Lim J, Mattews J, Norton A, Amess J, Lister T (1995) Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center. J Clin Oncol 13:140
4. Philip T, Guglielmi C, Hagenbeek A, Somers R, Van der Lelie H, Bron D, Sonneveld P, Gisselbrecht C, Cahn J, Harousseau J, Coiffier B, Biron P, Mandelli F, Chauvin F (1995) Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 333:1540
5. Young RC, Longo DL, Glatstein E, Ihde DC, Jaffe ES, DeVita VT (1988) The treatment of indolent lymphomas: watchful waiting vs aggressive combined modality treatment. Semin Hematol 25:11
6. Schouten HC, Bierman PJ, Vaughan WP, Kessinger A, Vose JM, Weisenburger DD, Armitage JO (1989) Autologous bone marrow transplantation in follicular non-Hodgkin's lymphoma before and after histologic transformation. Blood 74:2579
7. Freedman AS, Ritz J, Neuberg D, Anderson KC, Rabinowe SN, Mauch P, Takvorian T, Soiffer R, Blake K, Yeap B, Coral F, Helfin L, Nadler LM (1991) Autologous bone marrow transplantation in 69 patients with a history of low grade B cell non-Hodgkin's lymphoma. Blood 77:2524
8. Vose J, Bierman P, Armitage J (1991) High dose chemotherapy with stem cell rescue for the treatment of follicular low grade non-Hodgkin's lymphoma. Autologous Bone Marrow Transplantation. Proceedings of the Fifth International Symposium V: 479
9. Rohatiner A, Johnson P, Price C Arnott, SJ, Amess J. Norton A, Dorey E, Adams K, Whelan J, Matthews J, MacCallum P, Oza A, Lister T (1994) Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma. J Clin Oncol 12:1177
10. Colombat P, Donadio D, Fouillard L, Milpied N, Tilly H, Pico J, Abrgrall J, Coiffier B, Herbrecht R, Philip T (1994) Value of autologous bone marrow transplantation in follicular lymphoma: a France Autogreffe retrospective study of 42 patients. Bone Marrow Transplant 13:157
11. Haas R, Moos M, Karcher A, Mohle R, Witt B, Goldschmidt H, Fruhauf S, Flentje M, Wannenmacher M, Hunstein W (1994) Sequential high dose therapy with peripheral blood progenitor cell support in low grade non-Hodgkin's lymphoma. J Clin Oncol 12:1685
12. Bastion Y, Brice P, Haioun C, Sonet A, Salles G, Marolleau J, Espinouse D, Reyes F, Gisselbrecht C, Coiffier B (1995) Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma. Blood 86:3257
13. Haas R, Moos M, Mohle R, Dohner H, Witt B, Goldschmidt H, Murea S, Flentje M, Wannenmacher M, Hunstein W (1996) High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphoma. Bone Marrow Transplant 17:149
14. Williams C, Goldstone A, Pearce R, Philip T, Hartmann O, Colombat P, Santini G, Foulard L, Gorin N (1996) Purging of bone marrow in autologous bone marrow transplantation for non-Hodgkin's lymphoma: a case-matched comparison with unpurged cases by the European Blood and Marrow Transplant Lymphoma Registry. J Clin Oncol 14:2454
15. Bierman P, Vose J, Anderson J, Bishop M, Kessinger A, Armitage J (1997) High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma. J Clin Oncol 15:445
16. Fouillard L, Laporte J, Labopin M, Lesage S, Isnard F, Douay L, Lopez M, Aoudjhane M, Zunic P, Cheron N, Stachowiak J, Lemonnier M, Andreu G, Belkacemi Y, Noel-Walter M, Morel P, Fenaux P, Jouet J, Bauters F, Najman A, Gorin N (1998) Autologous stem-cell transplantation for non-Hodgkin's lymphomas: the role of graft purging and radiotherapy post-transplantation - results of a retrospective analysis on 120 patients autografted in a single institution. J Clin Oncol 16:2803
17. Acker B, Hoppe RT, Colby TV, Cox RS, Kaplan HS, Rosenberg SA (1983) Histologic conversion in the non-Hodgkin's lymphomas. J Clin Oncol 1:11
18. Yuen A, Kamel O, Halpern J, Horning S (1995) Long-term survival after histologie transformation of low-grade follicular lymphoma. J Clin Oncol 13:1726
19. Bastion Y, Sebban C, Berger F, Felman P, Salles G, Dumontet C, Bryon P, Coiffier B (1997) Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients. J Clin Oncol 15:1587
20. Gribben J, Freedman A, Woo S, Blake K, Shu R, G F, Longtine J, Pinkus G, Nadler L (1991) All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment. Blood 78:3275
21. Berinstein NL, Jamal HH, Kuzniar B, Klock RJ, Reis MD (1993) Sensitive and reproducible detection of occult disease in patients with follicular lymphoma by PCR amplification of t(14; 18) both pre- and post-treatment. Leukemia 7:113
22. Hickish TF, Purvies H, Mansi J, Soukop M, Cunningham D (1991) Molecular monitoring of low grade non-Hodgkin's lymphoma by gene amplification. Br J Cancer 64:1161
23. Lambrechts AC, Hupkes PE, Dorssers LCJ, van't Veer MB (1994) Clinical significance of translocation t(14;18) positive cells in the circulation of patients with stage III or IV follicular non-Hodgkin's lymphoma during first remission. J Clin Oncol 12:1541
24. Brenner M, Rill D, Moen R, Krance R, Mirro J, Anderson W, Ihle J (1993) Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 341:85
25. Deisseroth A, Zu Z, Claxton D, Hanania E, Fu S, Ellerson D, Goldberg L, Thomas M, Janicek K, Anderson W, Hester J, Korbling M, Durett A, Moen R, Berenson R, Heinfiled S, Maer J, Calvert L, Tibbits P, Talpaz M, Kantarkian H, Champlin R, Reading C (1994) Genetic marking shows that Ph + cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 83:3068
26. Gribben JG, Freedman AS, Neuberg D, Roy DC, Blake KW, Woo SD, Grossbard ML, Rabinowe SN, Coral F, Freeman GJ, et al (1991) Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med 325:1525
27. Kessinger A, Armitage JO, Smith DM, Landmark JD, Bierman PJ, Weisenburger DD (1989) High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma. Blood 74:1260
28. Van Besien K, Khouri I, Giralt S, McCarthy P, Mehra R, Andersson B, Przepiorka D, Gajewski J, Bellare N, Nath R, Romaguera J, McLaughlin P, Korbling M, Deisseroth A, Cabanillas F, Champlin R (1995) Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: the case for aggressive management. J Clin Oncol 13:1096
29. Van Besien K, Mehra R, Giralt S, Kantarjian H, Pugh W, Khouri I, Moon Y, Williams P, Andersson B, Przepiorka D, McCarthy P, Gajewski J, Deisseroth A, Cabanillas F, Champlin R (1996) Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity, and survival depend on disease histology. Am J Med 100:299
30. Verdonck L, Dekker A, Lokhorst H, Petersen E, Nieuwenhuis H (1997) Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma. Blood 90:4201
31. Juckett M, Rowlings P, Hessner M, Keever-Taylor C, Burns W, Camitta B, Casper J, Drobyski W, Hanson G, Horowitz M, Lawton C, Margolis J, Peitryga D, Vesole D (1998) T-cell-depleted allogeneic bone marrow transplantation for high-risk non-Hodgkin's lymphoma: clinical and molecular followup. Bone Marrow Transplant 21:893
32. Soiffer R, Freedman A. Neuberg D, Fisher D, Alyea E, Gribben J, Schlossman R, Bartlett-Pandite L, Kuhlman C, Murray C, Freeman A, Mauch P, Anderson K, Nadler L, Ritz J (1998) CD6+ T-cell-depleted allogeneic bone marrow transplantation for non-Hodgkin's lymphoma. Bone Marrow Transplant 21:1177
33. Jones R, Ambinder R, Piantadosi S, Santos G (1991) Evidence for a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation. Blood 77:649
34. Ratanatharathorn V, Uberti J, Karanes C, Abella E, Lum L, Momin F, Cummings G, Sensenbrenner L (1994) Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma. Blood 84:1050
35. Van Besien K, de Lima M, Giralt S, Moore D, Khouri I, Rondon G, Mehra R, Andersson B, Dyer C, Cleary K. Gajewski J, Champlin R (1997) Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect. Bone Marrow Transplant 19:977
36. Darrington D, Vose J, Anderson J, Bierman P, Bishop M, Chan W, Morris M, Reed E Sanger, WG, Tarantolo S, Weisenburger D, Kessinger A, Armitage J (1994) Incidence and characterization of secondary myelodysplastic syndrome following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies. J Clin Oncol 12:2527
37. Miller J, Arthur D, Litz C, Neglia J, Miller W, Weisdorf D (1994) Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy. Blood 83:3780
38. Stone R, Neuberg D, Soiffer R, Takvorian T, Whelan M, Rabinowe S, Aster J, Leavitt P, Mauch P, Freedman A. Nadler L (1994) Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma. J Clin Oncol 12:2535
39. Freedman A, Gribben J, Neuberg D, Mauch P, Soiffer R. Anderson K, Fisher D, Schlossman R, Kroon M, Ritz J, Nadler L (1997) Long term prolongation of disease-free and overall survival following autologous bone marrow transplantation in patients with advanced relapsed follicular lymphoma. Proc Am Soc Clin Oncol 16:89
40. Foran J, Apostolidis J, Papamichael D, Norton A, Matthews J, Amess J, Lister T, Rohatiner A (1998) High-dose therapy with autologous haematopoietic support in patients with transformed follicular lymphoma: a study of 27 patients from a single centre. Ann Oncol 9:865
41. Friedberg J, Neuberg D, Gribben J, Mauch P, Anderson K, Soiffer R, Takvorian T, Fisher D, Schlossman R, Jallow H, Kuhlman C, Ritz J (1998) Autologous bone marrow transplantation following histologic transformation of indolent B-cell non-Hodgkin's lymphoma. Blood 92:727a
42. Thomas ED, Clift RA (1989) Indications for marrow transplantation in chronic myelogenous leukemia. Blood 73:861
43. Freedman A, Gribben J, Neuberg D, Mauch P, Soiffer R, Anderson K, Pandite L, Robertson M, Kroon M, Ritz J. Nadler L (1996) High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission. Blood 88:2780
44. Horning S, Negrin R, Hoppe R, Chao N, Long G, Rosenberg S, Tierney K, Blume K (1997) High-dose therapy and autografting for follicular low-grade lymphoma in first remission: the Stanford experience. Blood 90:594
45. Tarella C, Corradini P, Caracciolo D, Astolfi M, Castellino C, Gavarotti P (1996) High-dose chemotherapy as upfront treatment in 35 patients with indolent lymphoma induces a high rate of durable clinical and molecular remission. Blood 88:121
46. van Besien K, Sobocinski K, Rowlings P, Murphy S, Armitage J, Bishop M, Chaekal O, Gale R, Klein J, Lazarus H, McCarthy P, Raemaekers J. Reiffers J, Phillips G, Schattenberg A, Verdonck L, Vose J, Horowitz M (1998) Allogeneic bone marrow transplantation for low-grade lymphoma. Blood 92:1832
47. Khouri I, Keating M, Korbling M, Przepiorka D, Anderlini P, O'Brien S, Giralt S, Ippoliti C, von Wolff B, Gajewski J, Donato M, Claxton D, Ueno N, Andersson B, Gee A, Champlin R (1998) Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. J Clin Oncol 16:2817
48. Klingemann H, Grigg A, Wilkie-Boyd K, Barnett M, Eaves A, Reece D, Shepard J, Phillips G (1991) Treatment with recombinant interferon (a-2b) early after bone marrow transplantation in patients at high risk for relapse. Blood 78:3306
49. Vey N, Biaise D. Tiberghein P, Attal M, Pico J, Reiffers J. Harrousseau J, Fiere D, Tabilio A, Gabus R, Brandely M, Maraninchi D (1996) A pilot study of autologous bone marrow transplantation followed by recombinant interleukin-2 in malignant lymphomas. Leuk Lymphoma 21:107
50. Schultze J, Cardoso A, Freeman G, Seamon M, Daley J, Pinkus G, Gribben J, Nadler L (1995) Follicular lymphomas can be induced to present alloantigen efficiently: a conceptual model to improve their tumor immunogenicity. Proc Natl Acad Sci U S A 92:8200
51. Kwak L, Campbell M, Czerwinski D, Hart S, Miller R, Levy R (1992) Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors. N Engl J Med 327:1209
52. Hsu F, Benike C, Fagnoni F, Liles T. Czerwinski D, Taidi B, Engleman E, Levy R (1996) Vaccination of patients with B-cell lymphoma using autologous antigen pulsed dendritic cells. Nat Med 2:52
53. Bendandi M, Gocke C, Kobrin C, Benko F, Sternas L, Watson T, Reynolds C, Kwak L (1998) Molecular complete remissions induced by patient-specific vaccination in most patients with follicular lymphoma. Blood 92:153
54. Pedrazzini A, Freedman A, Andersen J, Heflin L, Anderson K, Takvorian T, Canellos G, Whitman J, Coral F, Ritz J, Nadler L (1989) Anti-B cell monoclonal antibody purged autologous bone marrow transplantation for B cell non-Hodgkin's lymphoma: phenotypic reconstitution and B cell function. Blood 74:2203
55. Multani P, Grossbard M (1998) Monoclonal antibody-based therapies for hematologic malignancies. J Clin Oncol 16:3691
56. Grossbard M, Niedzwiecki D, Nadler L, et al (1998) Anti-B4-blocked ricin (anti-B4-bR) adjuvant therapy post-autologus bone marrow transplant (ABMT)(CALGB 9254): a phase III intergroup study. Proc Am Soc Clin Oncol 17: A8
57. Shan D, Ledbetter J, Press O (1998) Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies. Blood 91:1644
58. Kaminski M, Zasadny K, Francis I, Milik A, Ross C, Moon S, Crawford S, Burgess J, Petry N, Butchko G, Glenn S, Wahl R (1993) Radioimmunotherapy of B-cell lymphoma with anti-B1 (anti-CD20) antibody. N Engl J Med 329:459
59. Press O, Eary J, Appelbaum F, Martin P, Badger C, Nelp W, Glenn S, Butchko G. Fisher D, Porter B, Matthews D, Fisher L, Bernstein I (1993) Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support. N Engl J Med 329:1219
60. Press O, Eary J, Applebaum F, Martin P, Nelp W, Glenn S, Fisher D, Porter B, Matthews D, Gooley T. Bernstein I (1995) Phase II trial of iodine 131-B1 (anti-Cd20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas. Lancet 346:336
61. Kaminski M, Zasadny K, Francis I, Fenner M, Ross C, Milik A, Estes J, Tuck M, Regan D, Fisher S, Glenn S, Wahl R (1996) Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma. J Clin Oncol 14:1974
62. Liu S, Eary J, Petersdorf S, Martin P, Maloney D, Appelbaum F, Matthews D, Bush S, Durack L, Fisher D, Gooley T, Bernstein I, Press O (1998) Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue. J Clin Oncol 16:3270